An FDA advisory committee is holding a two-day meeting to consider whether to lift current restrictions on seven peptides that are widely promoted for wellness and health purposes. The review follows increased public interest, including support amplified by wellness influencers and other media figures. PBS reports that some public attention has included endorsements from Health Secretary Robert F. Kennedy Jr. and discussion of why people are injecting themselves with peptides.
NBC says the panel is examining the safety and effectiveness of the seven peptides, which have been marketed for a range of uses, including injuries and aging. NBC and PBS both reflect that the committee is weighing evidence as well as concerns raised by critics. Critics argue that there is not enough data to clearly establish the peptides’ safety and efficacy for the purposes for which they are being used and marketed.
The committee’s discussion is focused on whether regulatory changes could broaden access, while addressing potential risks tied to use that may outpace the current scientific evidence.
